1. Home
  2. ICUI vs LIVN Comparison

ICUI vs LIVN Comparison

Compare ICUI & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$136.75

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Logo LivaNova PLC

LIVN

LivaNova PLC

HOLD

Current Price

$73.60

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICUI
LIVN
Founded
1984
1987
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.5B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
ICUI
LIVN
Price
$136.75
$73.60
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$169.00
$72.43
AVG Volume (30 Days)
254.1K
798.2K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
100.62
N/A
EPS
1.20
0.40
Revenue
$2,231,262,000.00
N/A
Revenue This Year
N/A
$9.79
Revenue Next Year
$4.46
$6.63
P/E Ratio
$116.90
$182.69
Revenue Growth
N/A
N/A
52 Week Low
$107.02
$41.02
52 Week High
$160.29
$75.82

Technical Indicators

Market Signals
Indicator
ICUI
LIVN
Relative Strength Index (RSI) 64.77 61.09
Support Level $115.74 $61.63
Resistance Level $153.00 N/A
Average True Range (ATR) 5.28 2.34
MACD 1.92 0.11
Stochastic Oscillator 77.38 66.52

Price Performance

Historical Comparison
ICUI
LIVN

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

About LIVN LivaNova PLC

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: